Initial data suggest that ablation of VT in the presence of intracavitary thrombus is feasible, is associated with a similar success rate to historical studies in patients without thrombus, and has an acceptable risk of complications given the high-risk nature of patients with ES. Further data are needed; however, the presence of a laminated thrombus should not necessarily preclude ablation in patients who have failed medical therapy for VT in whom ablation is otherwise indicated.

This case series shows that the Szabo technique, in spite of some difficulties like wire entanglement, stent dislodgement and resistance during stent advancement, is a simple and feasible method for treating variety of ostial lesions precisely compared to conventional angioplasty.

The incidence of SCD is high in first month after STEMI, irrespective of LV function. The number of SCD is higher in Group B patients. Algorithms to assess risk of SCD in early post STEMI period are urgently needed.

Stent thrombosis (ST) is a persistent and important clinical problem. Stent thrombosis has been defined and classified by the Academic Research Consortium (ARC). We have reviewed the data available on the incidence of ST in various registries and trials. The incidence of ST is higher with DES compared to BMS. ST incidence is highest with first generation DES but reduces significantly with second and third generation DES. We have reviewed the factors which predict a higher incidence of ST. These can be divided into patient, lesion and procedure characteristics. The upcoming new technologies and their potential impact on ST have been discussed. Finally, the methods of minimising the incidence of ST in practice have been discussed. Keywords: Stent thrombosis; Coronary stent; Drug eluting stents

No abstract